Skip navigation
Please use this identifier to cite or link to this item:
Files in This Item:
File SizeFormat 
ARTIGO_G6pdDeficiencyLatin.pdf816,5 kBAdobe PDFView/Open
Title: G6PD deficiency in Latin America : systematic review on prevalence and variants
Authors: Monteiro, Wuelton Marcelo
Val, Fernando Fonseca de Almeida
Siqueira, André Machado
Franca, Gabriel Peixoto
Sampaio, Vanderson de Souza
Melo, Gisely Cardoso de
Almeida, Anne Cristine Gomes de
Brito, Marcelo
Peixoto, Henry Maia
Fuller, Douglas
Bassat, Quique
Romero, Gustavo Adolfo Sierra
Oliveira, Maria Regina Fernandes de
Lacerda, Marcus Vinícius Guimarães de
Assunto:: Glicosefosfato desidrogenase
Plasmodium vivax
Issue Date: 2014
Publisher: Instituto Oswaldo Cruz, Ministério da Saúde
Citation: MONTEIRO, Wuelton Marcelo et al. G6PD deficiency in Latin America: systematic review on prevalence and variants. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 109, n. 5, p. 553-568, ago. 2014. DOI: Disponível em: Acesso em: 21 jul. 2020.
Abstract: Plasmodium vivax radical cure requires the use of primaquine (PQ), a drug that induces haemolysis in glucose-6-phosphate dehydrogenase deficient (G6PDd) individuals, which further hampers malaria control efforts. The aim of this work was to study the G6PDd prevalence and variants in Latin America (LA) and the Caribbean region. A systematic search of the published literature was undertaken in August 2013. Bibliographies of manuscripts were also searched and additional references were identified. Low prevalence rates of G6PDd were documented in Argentina, Bolivia, Mexico, Peru and Uruguay, but studies from Curaçao, Ecuador, Jamaica, Saint Lucia, Suriname and Trinidad, as well as some surveys carried out in areas of Brazil, Colombia and Cuba, have shown a high prevalence (> 10%) of G6PDd. The G6PD A-202A mutation was the variant most broadly distributed across LA and was identified in 81.1% of the deficient individuals surveyed. G6PDd is a frequent phenomenon in LA, although certain Amerindian populations may not be affected, suggesting that PQ could be safely used in these specific populations. Population-wide use of PQ as part of malaria elimination strategies in LA cannot be supported unless a rapid, accurate and field-deployable G6PDd diagnostic test is made available.
Licença:: Memórias do Instituto Oswaldo Cruz - (CC BY-NC) - This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Fonte: g=en. Acesso em: 21 jul. 2020.
Appears in Collections:FMD - Artigos publicados em periódicos e preprints

Show full item record Recommend this item " class="statisticsLink btn btn-primary" href="/handle/10482/29137/statistics">

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.